These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7072211)

  • 21. [Choice of a calcium channel blocker].
    Grönhagen-Riska C
    Duodecim; 1997; 113(21):2181-6. PubMed ID: 10892116
    [No Abstract]   [Full Text] [Related]  

  • 22. [Growth hormone--a pathogenetic factor in chronic congestive heart failure?].
    Dreifuss PM
    Dtsch Med Wochenschr; 1996 Oct; 121(41):1279. PubMed ID: 8925768
    [No Abstract]   [Full Text] [Related]  

  • 23. [Capillary permeability and carbohydrate metabolic indices in circulatory failure].
    Rybachuk IA; Denisiuk VI
    Vrach Delo; 1982 Feb; (2):64-8. PubMed ID: 7073862
    [No Abstract]   [Full Text] [Related]  

  • 24. [The role of the GH/IGF-1 axis in cardiovascular physiopathology and therapy: the lessons from animal studies].
    Cittadini A; Durante Mangoni E; Palmieri EA; Casaburi C; Longobardi S; Di Rella F; Fazio S; Saccà L
    Cardiologia; 1998 Nov; 43(11):1185-92. PubMed ID: 9922584
    [No Abstract]   [Full Text] [Related]  

  • 25. [Digoxin in chronic heart failure].
    Motz W
    Dtsch Med Wochenschr; 1993 Dec; 118(48):1786. PubMed ID: 8253039
    [No Abstract]   [Full Text] [Related]  

  • 26. [Essential phospholipids in combined therapy of chronic circulatory insufficiency].
    Golochevskaia VS; Baranskaia EK; Trofimenko IV; Balakhonova NP; Burmakin IA; Kop'ev VI; Zadorozhnaia OO
    Klin Med (Mosk); 1997; 75(5):30-3. PubMed ID: 9235405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998].
    Jenni D; Osterwalder R; Osswald S; Buser P; Pfisterer M
    Praxis (Bern 1994); 2001 Oct; 90(41):1759-65. PubMed ID: 11692790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Crataegus in heart failure and coronary heart disease. What is the value of this additional medication?].
    MMW Fortschr Med; 2001 Feb; 143(6):56. PubMed ID: 11252428
    [No Abstract]   [Full Text] [Related]  

  • 29. Drugs for treatment of chronic heart failure.
    Treat Guidel Med Lett; 2009 Jul; 7(83):53-6. PubMed ID: 19556942
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug therapy in chronic heart failure].
    Airaksinen J; Luomanmäki K
    Duodecim; 1997; 113(10):965-71. PubMed ID: 11466831
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of refractory heart failure.
    Dei Cas L; Metra M; Nodari S; Raddino R; Bonandi L; Visioli O
    Cardiologia; 1992 Jul; 37(7):501-5. PubMed ID: 8521428
    [No Abstract]   [Full Text] [Related]  

  • 32. [The clinical efficacy of taufon in the combined treatment of patients with chronic circulatory failure].
    Zavolovskaia LI; Elizarova EP; Orlov VA
    Eksp Klin Farmakol; 1995; 58(6):29-32. PubMed ID: 8704607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetic characteristics of lidocaine in patients with circulatory failure].
    Kukes VG; Gneushev ET; Utlinskaia MG; Burian EF; Starodubtsev AK
    Farmakol Toksikol; 1981; 44(4):447-50. PubMed ID: 7286204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Controversial effects of aspirin on coronary artery disease and chronic heart failure].
    Xu CB
    Zhonghua Nei Ke Za Zhi; 2003 Sep; 42(9):603-4. PubMed ID: 14738053
    [No Abstract]   [Full Text] [Related]  

  • 35. [Which interactions are there for equal doses of acetylsalicylic acid and ACE inhibitors?].
    Joost HG
    Dtsch Med Wochenschr; 2003 Feb; 128(8):398. PubMed ID: 12594628
    [No Abstract]   [Full Text] [Related]  

  • 36. [The treatment of heart diseases from various causes with the combination preparation Spasmo-Guttacor].
    Wimmer H; Spesshardt K
    Med Welt; 1966 Sep; 37():1984-5. PubMed ID: 6010242
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of molsidomine preparations on the coronary and myocardial reserves of patients with IHD complicated by circulatory failure].
    Ol'binskaia LI; Sizova ZhM; Alekperov EE
    Ter Arkh; 1994; 66(8):30-2. PubMed ID: 7985149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-blockers in chronic heart failure.
    Gheorghiade M; Colucci WS; Swedberg K
    Circulation; 2003 Apr; 107(12):1570-5. PubMed ID: 12668487
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta-blocking agents in heart failure: modern concepts and overview.
    Strauer BE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S129-32. PubMed ID: 11527116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemodynamic effect of molsidomine in coronary patients with heart failure with clinically manifest nitrate tolerance].
    Störk T; Möckel M; Störk S; Piske G; Danne O; Bodemann T; Müller R; Eichstädt H; Hochrein H
    Z Kardiol; 1993 May; 82(5):293-301. PubMed ID: 8328179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.